A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6 methylguanine DNA methyltransferase) Glioblastoma - Regional Cancer Care Associates LLC

Clinical Trials

A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6 methylguanine DNA methyltransferase) Glioblastoma

Type of Cancer
Neuro-Oncology
Locations
Hackensack
Sponsor
Bristol-Myers Squibb
Protocol Number
CA209-548
Cancer Diagnosis
To Learn More Call
201-510-0910